 |
인쇄하기
취소
|
Whanin wins patent suit against SK Chemicals
Whanin Pharm has won the right to market a combination form of ginkgo biloba extract and cilostazol.
The company announced Monday that it secured the right to sell its new platelet aggregation inhibitor on Korean market after the patent court rejected the Korean Intellectual Property Tribunal's previous ruling in favor of SK that summited a preliminary injunction against its Korea rival.
...
The company announced Monday that it secured the right to sell its new platelet aggregation inhibitor on Korean market after the patent court rejected the Korean Intellectual Property Tribunal's previous ruling in favor of SK that summited a preliminary injunction against its Korea rival.
...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.